Cover
Cover | Nov. 30, 2021 |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | On December 1, 2021, enVVeno Medical Corporation (the “Company”) filed a Current Report on Form 8-K with the Securities and Exchange Commission to report the results of the matters submitted to a vote by the Company’s stockholders at the Company’s Annual Meeting of Stockholders (the “Annual Meeting”) held on November 30, 2021. This Form 8-K/A is being filed for the sole purpose of correcting the number of votes received for each of the proposals. There is no change to the results of any of the proposals. |
Document Period End Date | Nov. 30, 2021 |
Entity File Number | 001-38325 |
Entity Registrant Name | enVVeno Medical Corporation |
Entity Central Index Key | 0001661053 |
Entity Tax Identification Number | 33-0936180 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 70 Doppler |
Entity Address, City or Town | Irvine |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92618 |
City Area Code | (949) |
Local Phone Number | 261-2900 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | true |
Common Stock, par value $0.00001 per share | |
Title of 12(b) Security | Common Stock, par value $0.00001 per share |
Trading Symbol | NVNO |
Security Exchange Name | NASDAQ |
Warrants to Purchase Common Stock | |
Title of 12(b) Security | Warrants to Purchase Common Stock |
Trading Symbol | NVNOW |
Security Exchange Name | NASDAQ |